EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma

Xiaowang Niu, Guangzhao Li, Ulf D Kahlert, Leili Ding, Jing Zheng, Chen Li, Wenjie Shi iD, Lifen Huang, Zhengquan Yu

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xiaowang Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Apoptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disulfidptosis, a new form of programmed cell death, plays a role in multiple types of cancer. However, research on disulfidptosis in glioma is lacking. A disulfidptosis‐associated risk score was constructed using Cox regression modelling, while LASSO regression was applied for feature selection. To explore the relationship between the risk score and the immune microenvironment, we employed CIBERSORT, ssGSEA and ESTIMATE algorithms. Additionally, wet lab experiments were conducted to validate the functional role of the key disulfidptosis gene RPN1, demonstrating its ability to promote glioma cell proliferation and migration. Disulfidptosis genes were significantly upregulated in gliomas, influencing clinical features and survival. The risk score effectively predicted OS and varied among clinical subgroups. High‐risk scores correlated with tumour growth, invasion and immunosuppression. Patients with different risk scores showed distinct immune cell infiltration patterns. Most immune checkpoints and chemokines were positively associated with risk scores. Laboratory findings confirmed that RPN1 significantly promoted glioma cell proliferation and migration. Disulfidptosis‐based risk assessment stratifies glioma prognosis and reveals immune microenvironment characteristics, offering insights for personalised treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsApoptosisHumansPrognosisTumor MicroenvironmentRisk AssessmentCell ProliferationGene Expression Regulation, NeoplasticBiomarkers, TumorCell MovementMaleFemaleCell Line, TumorDisulfidptosis

Stichwörter der Autor:innen

disulfidptosisgliomaimmune microenvironmentprognosisrisk score

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Neurosurgery, Suqian Hospital Affiliated to Xuzhou Medical University, Suqian, China.
  • Department of Neurosurgery, Hefei First People's Hospital, Hefei, China.
  • Molecular and Experimental Surgery, Clinic for General-, Visceral -, Vascular- and Transplantation Surgery, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg, Germany.
  • Nantong University, Nantong, China.
  • Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

ORCID-Profile: Wenjie Shi

Zitieren

APA

Niu, X., Li, G., Kahlert, U. D., Ding, L., Zheng, J., Li, C., Shi, W., Huang, L., & Yu, Z. (2025). Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70429

Vancouver

Niu X, Li G, Kahlert UD, Ding L, Zheng J, Li C, et al. Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70429

BibTeX
@article{Niu2025,
  author = {Niu, Xiaowang and Li, Guangzhao and Kahlert, Ulf D and Ding, Leili and Zheng, Jing and Li, Chen and Shi, Wenjie and Huang, Lifen and Yu, Zhengquan},
  title = {Integrative Disulfidptosis‐Based Risk Assessment for Prognostic Stratification and Immune Profiling in Glioma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70429}
}
Kostenlos starten →